Docket Room.
SB 2021·OK·senate

Pharmaceutical advertising; prohibiting certain direct-to-consumer advertising; providing civil and criminal penalties. Effective date. Emergency.

FailedFiled Feb 2, 2026
Sponsor: Deevers
Latest Action

Second Reading referred to Business and Insurance

Feb 3, 2026

Email me when SB 2021 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track SB 2021. By continuing you agree to the Terms and Privacy Policy.

Summary

The bill bans pharmaceutical companies from advertising prescription drugs directly to Oklahoma residents through TV, radio, print, online, and other media. Affected companies must file annual compliance reports with the Attorney General and face escalating civil fines, misdemeanor or felony charges for violations. The measure aims to protect public health by stopping misleading drug promotions.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about SB 2021

3 free questions a day, no account

History

  1. Second Reading referred to Business and Insurance
  2. First Reading
  3. Authored by Senator Deevers

Sponsors

  • Deevers · sponsor

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when SB 2021 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track SB 2021 free

Or ask your AI assistant about SB 2021 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice